These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


147 related items for PubMed ID: 12525555

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A human homologue of the Drosophila melanogaster sluggish-A (proline oxidase) gene maps to 22q11.2, and is a candidate gene for type-I hyperprolinaemia.
    Campbell HD, Webb GC, Young IG.
    Hum Genet; 1997 Nov; 101(1):69-74. PubMed ID: 9385373
    [Abstract] [Full Text] [Related]

  • 4. [Hyperprolinemia type I].
    Endo F.
    Ryoikibetsu Shokogun Shirizu; 1998 Nov; (18 Pt 1):152-4. PubMed ID: 9590013
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inborn errors of proline metabolism.
    Mitsubuchi H, Nakamura K, Matsumoto S, Endo F.
    J Nutr; 2008 Oct; 138(10):2016S-2020S. PubMed ID: 18806117
    [Abstract] [Full Text] [Related]

  • 7. Early neurological phenotype in 4 children with biallelic PRODH mutations.
    Afenjar A, Moutard ML, Doummar D, Guët A, Rabier D, Vermersch AI, Mignot C, Burglen L, Heron D, Thioulouse E, de Villemeur TB, Campion D, Rodriguez D.
    Brain Dev; 2007 Oct; 29(9):547-52. PubMed ID: 17412540
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association of hyperprolinaemia type I and heparin cofactor II deficiency with CATCH 22 syndrome: evidence for a contiguous gene syndrome locating the proline oxidase gene.
    Jaeken J, Goemans N, Fryns JP, François I, de Zegher F.
    J Inherit Metab Dis; 1996 Oct; 19(3):275-7. PubMed ID: 8803768
    [Abstract] [Full Text] [Related]

  • 11. Type I hyperprolinemia: genotype/phenotype correlations.
    Guilmatre A, Legallic S, Steel G, Willis A, Di Rosa G, Goldenberg A, Drouin-Garraud V, Guet A, Mignot C, Des Portes V, Valayannopoulos V, Van Maldergem L, Hoffman JD, Izzi C, Espil-Taris C, Orcesi S, Bonafé L, Le Galloudec E, Maurey H, Ioos C, Afenjar A, Blanchet P, Echenne B, Roubertie A, Frebourg T, Valle D, Campion D.
    Hum Mutat; 2010 Aug; 31(8):961-5. PubMed ID: 20524212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of PRODH mutations in Korean neonates with type I hyperprolinemia.
    Jang MA, Kim BC, Ki CS, Lee SY, Kim JW, Choi TY, Lee DH, Song J, Lee YW, Park HD.
    Ann Clin Lab Sci; 2013 Aug; 43(1):31-6. PubMed ID: 23462603
    [Abstract] [Full Text] [Related]

  • 14. Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation.
    Di Rosa G, Pustorino G, Spano M, Campion D, Calabrò M, Aguennouz M, Caccamo D, Legallic S, Sgro DL, Bonsignore M, Tortorella G.
    Psychiatr Genet; 2008 Feb; 18(1):40-2. PubMed ID: 18197084
    [Abstract] [Full Text] [Related]

  • 15. Intravenous proline tolerance in a patient with hyperprolinaemia type II and his relatives.
    Similä S.
    Helv Paediatr Acta; 1970 Jul; 25(3):287-92. PubMed ID: 5518053
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Asymptomatic type II hyperprolinaemia associated with hyperglycinaemia in three sibs.
    Pavone L, Mollica F, Levy HL.
    Arch Dis Child; 1975 Aug; 50(8):637-41. PubMed ID: 1200680
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Dietary treatment in hyperprolinaemia type II.
    Similä S.
    Acta Paediatr Scand; 1974 Mar; 63(2):249-56. PubMed ID: 4820590
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.